These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies. Modi ME; Young LJ Horm Behav; 2012 Mar; 61(3):340-50. PubMed ID: 22206823 [TBL] [Abstract][Full Text] [Related]
27. Intranasal oxytocin and OXTR genotype effects on resting state functional connectivity: A systematic review. Seeley SH; Chou YH; O'Connor MF Neurosci Biobehav Rev; 2018 Dec; 95():17-32. PubMed ID: 30243577 [TBL] [Abstract][Full Text] [Related]
28. Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders. Tachibana M; Kagitani-Shimono K; Mohri I; Yamamoto T; Sanefuji W; Nakamura A; Oishi M; Kimura T; Onaka T; Ozono K; Taniike M J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):123-7. PubMed ID: 23480321 [TBL] [Abstract][Full Text] [Related]
29. Adaptive coding of the value of social cues with oxytocin, an fMRI study in autism spectrum disorder. Andari E; Richard N; Leboyer M; Sirigu A Cortex; 2016 Mar; 76():79-88. PubMed ID: 26872344 [TBL] [Abstract][Full Text] [Related]
30. The acute effects of intranasal oxytocin administration on endocrine and sexual function in males. Burri A; Heinrichs M; Schedlowski M; Kruger TH Psychoneuroendocrinology; 2008 Jun; 33(5):591-600. PubMed ID: 18375074 [TBL] [Abstract][Full Text] [Related]
31. CSF and blood oxytocin concentration changes following intranasal delivery in macaque. Dal Monte O; Noble PL; Turchi J; Cummins A; Averbeck BB PLoS One; 2014; 9(8):e103677. PubMed ID: 25133536 [TBL] [Abstract][Full Text] [Related]
32. Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis. Bürkner PC; Williams DR; Simmons TC; Woolley JD Schizophr Bull; 2017 Oct; 43(6):1291-1303. PubMed ID: 28586471 [TBL] [Abstract][Full Text] [Related]
33. Opportunities and challenges for intranasal oxytocin treatment studies in nonhuman primates. Bauman MD; Murai T; Hogrefe CE; Platt ML Am J Primatol; 2018 Oct; 80(10):e22913. PubMed ID: 30281820 [TBL] [Abstract][Full Text] [Related]
34. Intranasal oxytocin modulates EEG mu/alpha and beta rhythms during perception of biological motion. Perry A; Bentin S; Shalev I; Israel S; Uzefovsky F; Bar-On D; Ebstein RP Psychoneuroendocrinology; 2010 Nov; 35(10):1446-53. PubMed ID: 20493637 [TBL] [Abstract][Full Text] [Related]
35. Oxytocin and psychotherapy: a pilot study of its physiological, behavioral and subjective effects in males with depression. MacDonald K; MacDonald TM; Brüne M; Lamb K; Wilson MP; Golshan S; Feifel D Psychoneuroendocrinology; 2013 Dec; 38(12):2831-43. PubMed ID: 23810433 [TBL] [Abstract][Full Text] [Related]
36. Intranasal administration of oxytocin: behavioral and clinical effects, a review. Veening JG; Olivier B Neurosci Biobehav Rev; 2013 Sep; 37(8):1445-65. PubMed ID: 23648680 [TBL] [Abstract][Full Text] [Related]
37. Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research. Quintana DS; Lischke A; Grace S; Scheele D; Ma Y; Becker B Mol Psychiatry; 2021 Jan; 26(1):80-91. PubMed ID: 32807845 [TBL] [Abstract][Full Text] [Related]
39. [Therapeutic effects of oxytocin in autism: Current status of the research]. Gauthier C; Doyen C; Amado I; Lôo H; Gaillard R Encephale; 2016 Feb; 42(1):24-31. PubMed ID: 26797566 [TBL] [Abstract][Full Text] [Related]
40. Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research. Guastella AJ; Hickie IB; McGuinness MM; Otis M; Woods EA; Disinger HM; Chan HK; Chen TF; Banati RB Psychoneuroendocrinology; 2013 May; 38(5):612-25. PubMed ID: 23265311 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]